We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOA:NYSEFinance of America Companies Inc. Analysis

Data as of 2026-09-16 - not real-time

$14.85

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Finance of America Companies Inc. is priced at $14.85 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 37.5%. With RSI at 17.7 the momentum picture is oversold, alongside a bearish MACD signal. Watch $14.60 as support and $21.68 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 2.9 versus a 16.0 sector average, below the peer group. The average analyst target implies 108.8% above today's level. Revenue is contracting at 64.8% on a -0.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 32.3%, a beta of 1.44 and a maximum drawdown of 47.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Strong operational performance and strategic MSR acquisition position the company for continued momentum despite market...Finance of America Companies FOA delivered earnings and revenue surprises of -22.Price-action only: Finance Of America Companies Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 17.7 signals oversold conditions
  • Trading below the 200-day average of 21.11

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 17.7 signals oversold conditions
  • P/E of 2.9 versus sector average of 16.0

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 2.9 versus sector average of 16.0
  • Negative profit margin of -0.1%
  • Analyst targets imply +108.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-64.80%
Profit Margin-0.10%
P/E Ratio2.9
ROE-9.93%
ROA-0.13%
Debt/Equity2968.47
P/B Ratio0.4
Op. Cash Flow$-555315968
Industry P/E16.0

Technical Analysis

TrendBearish
RSI17.7
Support$14.60
Resistance$21.68
MA 20$17.57
MA 50$21.07
MA 200$21.11
MACDBearish
VolumeStable
Fear & Greed Index91.39

Valuation

Target Price$31.00
Upside/Downside108.75%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.44
Volatility32.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.